Other
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Medtronic Cash Provided by (Used in) Operating Activity, Including Discontinued Operation decreased by 57.0% to $1.09B in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $986.00M to $1.09B. Over 4 years (FY 2021 to FY 2025), Cash Provided by (Used in) Operating Activity, Including Discontinued Operation shows an upward trend with a 3.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025
How to read this metric
A comprehensive measure of the company's total cash generation efficiency.
Detailed definition
The consolidated net cash flow from operating activities, including both continuing and discontinued operations. It prov...
Peer comparison
Standard consolidated cash flow metric used by all global enterprises.
Metric ID:
other_net_cash_provided_by_used_in_operating_activitiesHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.75B | $1.29B | $713.00M | $3.28B | $2.06B | $1.08B | $453.00M | $2.04B | $2.46B | $875.00M | $1.07B | $2.07B | $2.78B | $986.00M | $1.03B | $2.50B | $2.53B | $1.09B |
| QoQ Change | — | -26.0% | -44.8% | +360.6% | -37.4% | -47.4% | -58.2% | +351.0% | +20.4% | -64.4% | +22.2% | +93.3% | +34.4% | -64.5% | +4.2% | +143.7% | +1.0% | -57.0% |
| YoY Change | — | — | — | — | +17.9% | -16.2% | -36.5% | -37.8% | +19.6% | -19.2% | +136.0% | +1.1% | +12.9% | +12.7% | -3.9% | +21.2% | -9.0% | +10.3% |
Range$453.00M – $3.28B
CAGR-10.5%
Avg YoY Growth+7.8%
Median YoY Growth+5.7%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Medtronic's cash provided by (used in) operating activity, including discontinued operation?
- Medtronic (MDT) reported cash provided by (used in) operating activity, including discontinued operation of $1.09B in Q2 2025.
- How has Medtronic's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Medtronic's cash provided by (used in) operating activity, including discontinued operation increased by 10.3% year-over-year, from $986.00M to $1.09B.
- What is the long-term trend for Medtronic's cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), Medtronic's cash provided by (used in) operating activity, including discontinued operation has grown at a 3.1% compound annual growth rate (CAGR), from $6.24B to $7.04B.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Total net cash flow from all operating activities, including discontinued units.